KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Cash from Financing Activities: 2009-2024

Historic Cash from Financing Activities for Bausch Health Companies (BHC) over the last 16 years, with Dec 2024 value amounting to -$868.0 million.

  • Bausch Health Companies' Cash from Financing Activities fell 280.42% to -$719.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$422.0 million, marking a year-over-year increase of 59.11%. This contributed to the annual value of -$868.0 million for FY2024, which is 158.85% down from last year.
  • As of FY2024, Bausch Health Companies' Cash from Financing Activities stood at -$868.0 million, which was down 158.85% from $1.5 billion recorded in FY2023.
  • Bausch Health Companies' 5-year Cash from Financing Activities high stood at $1.5 billion for FY2023, and its period low was -$2.3 billion during FY2020.
  • In the last 3 years, Bausch Health Companies' Cash from Financing Activities had a median value of -$474.0 million in 2022 and averaged $44.3 million.
  • As far as peak fluctuations go, Bausch Health Companies' Cash from Financing Activities plummeted by 258.97% in 2020, and later surged by 411.18% in 2023.
  • Over the past 5 years, Bausch Health Companies' Cash from Financing Activities (MRY) stood at -$2.3 billion in 2020, then skyrocketed by 34.05% to -$1.5 billion in 2021, then surged by 68.67% to -$474.0 million in 2022, then soared by 411.18% to $1.5 billion in 2023, then plummeted by 158.85% to -$868.0 million in 2024.
  • Its Cash from Financing Activities stands at -$868.0 million for FY2024, versus $1.5 billion for FY2023 and -$474.0 million for FY2022.